Abstract
At its most fundamental level the goal of genetics is to connect genotype to phenotype. This question is asked at a basic level evaluating the role of genes and pathways in genetic model organism. Increasingly, this question is being asked in the clinic. Genomes of individuals and populations are being sequenced and compared. The challenge often comes at the stage of analysis. The variant positions are analyzed with the hope of understanding human disease. However after a genome or exome has been sequenced, the researcher is often deluged with hundreds of potentially relevant variations. Traditionally, amino-acid changing mutations were considered the tractable class of disease-causing mutations; however, mutations that disrupt noncoding elements are the subject of growing interest. These noncoding changes are a major avenue of disease (e.g., one in three hereditary disease alleles are predicted to affect splicing). Here, we review some current practices of medical genetics, the basic theory behind biochemical binding and functional assays, and then explore technical advances in how variations that alter RNA protein recognition events are detected and studied. These advances are advances in scale—high-throughput implementations of traditional biochemical assays that are feasible to perform in any molecular biology laboratory. This chapter utilizes a case study approach to illustrate some methods for analyzing polymorphisms. The first characterizes a functional intronic SNP that deletes a high affinity PTB site using traditional low-throughput biochemical and functional assays. From here we demonstrate the utility of high-throughput splicing and spliceosome assembly assays for screening large sets of SNPs and disease alleles for allelic differences in gene expression. Finally we perform three pilot drug screens with small molecules (G418, tetracycline, and valproic acid) that illustrate how compounds that rescue specific instances of differential pre-mRNA processing can be discovered.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, Gibbs RA, Hurles ME, McVean GA (2010) A map of human genome variation from population-scale sequencing. Nature 467(7319):1061–1073. doi:10.1038/nature09534
Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, Kang HM, Marth GT, McVean GA (2012) An integrated map of genetic variation from 1,092 human genomes. Nature 491(7422):56–65. doi:10.1038/nature11632
Ars E, Serra E, Garcia J, Kruyer H, Gaona A, Lazaro C, Estivill X (2000) Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. Hum Mol Genet 9(2):237–247
Auweter SD, Oberstrass FC, Allain FHT (2006) Sequence-specific binding of single-stranded RNA: is there a code for recognition? Nucleic Acids Res 34(17):4943–4959. doi:10.1093/nar/gkl620
Berg MG, Wan L, Younis I, Diem MD, Soo M, Wang C, Dreyfuss G (2012) A quantitative high-throughput in vitro splicing assay identifies inhibitors of spliceosome catalysis. Mol Cell Biol 32(7):1271–1283. doi:10.1128/MCB.05788-11
Berget SM (1995) Exon recognition in vertebrate splicing. J Biol Chem 270(6):2411–2414
Bessonov S, Anokhina M, Krasauskas A, Golas MM, Sander B, Will CL, Urlaub H, Stark H, Luhrmann R (2010) Characterization of purified human Bact spliceosomal complexes reveals compositional and morphological changes during spliceosome activation and first step catalysis. RNA 16(12):2384–2403. doi:10.1261/rna.2456210
Boutz PL, Stoilov P, Li Q, Lin CH, Chawla G, Ostrow K, Shiue L, Ares M Jr, Black DL (2007) A post-transcriptional regulatory switch in polypyrimidine tract-binding proteins reprograms alternative splicing in developing neurons. Genes Dev 21(13):1636–1652
Brunak S, Engelbrecht J, Knudsen S (1991) Prediction of human mRNA donor and acceptor sites from the DNA sequence. J Mol Biol 220(1):49–65
Buratti E, Chivers M, Kralovicova J, Romano M, Baralle M, Krainer AR, Vorechovsky I (2007) Aberrant 5´ splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization. Nucleic Acids Res 35(13):4250–4263. doi:10.1093/nar/gkm402
Burrows NP, Nicholls AC, Richards AJ, Luccarini C, Harrison JB, Yates JR, Pope FM (1998) A point mutation in an intronic branch site results in aberrant splicing of COL5A1 and in Ehlers-Danlos syndrome type II in two British families. Am J Hum Genet 63(2):390–398. doi:10.1086/301948
Bustamante CD, Burchard EG, De la Vega FM (2011) Genomics for the world. Nature 475(7355):163–165. doi:10.1038/475163a
Carmel I, Tal S, Vig I, Ast G (2004) Comparative analysis detects dependencies among the 5´ splice-site positions. RNA 10(5):828–840
Cartegni L, Chew SL, Krainer AR (2002) Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 3(4):285–298. doi:10.1038/nrg775
Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR (2003) ESEfinder: A web resource to identify exonic splicing enhancers. Nucleic Acids Res 31(13):3568–3571
Casto AM, Feldman MW (2011) Genome-wide association study SNPs in the human genome diversity project populations: does selection affect unlinked SNPs with shared trait associations? PLoS Genet 7(1):e1001266. doi:10.1371/journal.pgen.1001266
Chang B, Levin J, Thompson WA, Fairbrother WG (2009) High-throughput binding analysis determines the binding specificity of ASF/SF2 on alternatively spliced human pre-mRNAs. Comb Chem High Throughput Screen 13(3):242–252
Chasin LA (2007) Searching for splicing motifs. Adv Exp Med Biol 623:85–106
Chen IT, Chasin LA (1994) Large exon size does not limit splicing in vivo. Mol Cell Biol 14(3):2140–2146
Cho DH, Tapscott SJ (2007) Myotonic dystrophy: emerging mechanisms for DM1 and DM2. Biochim Biophys Acta 1772(2):195–204. doi:10.1016/j.bbadis.2006.05.013
Chodosh LA (2001) UV crosslinking of proteins to nucleic acids. Curr Protoc Mol Biol Chapter 12: Unit 12 15
Clark TA, Sugnet CW, Ares M Jr (2002) Genomewide analysis of mRNA processing in yeast using splicing-specific microarrays. Science 296(5569):907–910. doi:10.1126/science.1069415
Cooper TA (2005) Use of minigene systems to dissect alternative splicing elements. Methods 37(4):331–340
Coulter LR, Landree MA, Cooper TA (1997) Identification of a new class of exonic splicing enhancers by in vivo selection. Mol Cell Biol 17(4):2143–2150
Crotti L, Lewandowska MA, Schwartz PJ, Insolia R, Pedrazzini M, Bussani E, Dagradi F, George AL Jr, Pagani F (2009) A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome. Heart Rhythm 6(2):212–218. doi:10.1016/j.hrthm.2008.10.044
Damgaard CK, Tange TO, Kjems J (2002) hnRNP A1 controls HIV-1 mRNA splicing through cooperative binding to intron and exon splicing silencers in the context of a conserved secondary structure. RNA 8(11):1401–1415
Das MK, Dai HK (2007) A survey of DNA motif finding algorithms. BMC Bioinformatics 8(Suppl 7):S21, doi:1471-2105-8-S7-S21 [pii] 10.1186/1471-2105-8-S7-S21
Desmet FO, Hamroun D, Lalande M, Collod-Beroud G, Claustres M, Beroud C (2009) Human splicing finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res 37(9):e67. doi:10.1093/nar/gkp215
Dickson SP, Wang K, Krantz I, Hakonarson H, Goldstein DB (2010) Rare variants create synthetic genome-wide associations. PLoS Biol 8(1):e1000294. doi:10.1371/journal.pbio.1000294
Dignam JD, Lebovitz RM, Roeder RG (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11(5):1475–1489
Ding Y, Chan CY, Lawrence CE (2004) Sfold web server for statistical folding and rational design of nucleic acids. Nucleic Acids Res 32(Web Server issue):W135–W141, doi:10.1093/nar/gkh449
Divina P, Kvitkovicova A, Buratti E, Vorechovsky I (2009) Ab initio prediction of mutation-induced cryptic splice-site activation and exon skipping. Eur J Hum Genet 17(6):759–765. doi:10.1038/ejhg.2008.257
Djordjevic M (2007) SELEX experiments: new prospects, applications and data analysis in inferring regulatory pathways. Biomol Eng 24(2):179–189
Fairbrother WG, Chasin LA (2000) Human genomic sequences that inhibit splicing. Mol Cell Biol 20(18):6816–6825
Fairbrother WG, Yeh RF, Sharp PA, Burge CB (2002) Predictive identification of exonic splicing enhancers in human genes. Science 297(5583):1007–1013. doi:10.1126/science.1073774
Fairbrother WG, Yeo GW, Yeh R, Goldstein P, Mawson M, Sharp PA, Burge CB (2004) RESCUE-ESE identifies candidate exonic splicing enhancers in vertebrate exons. Nucleic Acids Res 32(Web Server issue):W187–W190, doi:10.1093/nar/gkh393
Ferraris L, Stewart AP, Gemberling MP, Reid DC, Lapadula MJ, Thompson WA, Fairbrother WG (2011a) High-throughput mapping of protein occupancy identifies functional elements without the restriction of a candidate factor approach. Nucleic Acids Res 39(6):e33. doi:10.1093/nar/gkq1213
Ferraris L, Stewart AP, Kang J, DeSimone AM, Gemberling M, Tantin D, Fairbrother WG (2011b) Combinatorial binding of transcription factors in the pluripotency control regions of the genome. Genome Res 21(7):1055–1064. doi:10.1101/gr.115824.110
Folco EG, Lei H, Hsu JL, Reed R (2012) Small-scale nuclear extracts for functional assays of gene-expression machineries. J Vis Exp. (64). doi:10.3791/4140
Fox-Walsh KL, Dou Y, Lam BJ, Hung SP, Baldi PF, Hertel KJ (2005) The architecture of pre-mRNAs affects mechanisms of splice-site pairing. Proc Natl Acad Sci U S A 102(45):16176–16181. doi:10.1073/pnas.0508489102
Furneaux HM, Perkins KK, Freyer GA, Arenas J, Hurwitz J (1985) Isolation and characterization of two fractions from HeLa cells required for mRNA splicing in vitro. Proc Natl Acad Sci U S A 82(13):4351–4355
Girard C, Will CL, Peng J, Makarov EM, Kastner B, Lemm I, Urlaub H, Hartmuth K, Luhrmann R (2012) Post-transcriptional spliceosomes are retained in nuclear speckles until splicing completion. Nat Commun 3:994. doi:10.1038/ncomms1998
Gonzaga-Jauregui C, Lupski JR, Gibbs RA (2012) Human genome sequencing in health and disease. Annu Rev Med 63:35–61. doi:10.1146/annurev-med-051010-162644
Gooding C, Clark F, Wollerton MC, Grellscheid SN, Groom H, Smith CW (2006) A class of human exons with predicted distant branch points revealed by analysis of AG dinucleotide exclusion zones. Genome Biol 7(1):R1
Gopinath SC (2007) Methods developed for SELEX. Anal Bioanal Chem 387(1):171–182
Goren A, Ram O, Amit M, Keren H, Lev-Maor G, Vig I, Pupko T, Ast G (2006) Comparative analysis identifies exonic splicing regulatory sequences–The complex definition of enhancers and silencers. Mol Cell 22(6):769–781. doi:10.1016/j.molcel.2006.05.008
Gozani O, Patton JG, Reed R (1994) A novel set of spliceosome-associated proteins and the essential splicing factor PSF bind stably to pre-mRNA prior to catalytic step II of the splicing reaction. EMBO J 13(14):3356–3367
Gravel S, Henn BM, Gutenkunst RN, Indap AR, Marth GT, Clark AG, Yu F, Gibbs RA, Bustamante CD (2011) Demographic history and rare allele sharing among human populations. Proc Natl Acad Sci U S A 108(29):11983–11988. doi:10.1073/pnas.1019276108
Halvorsen M, Martin JS, Broadaway S, Laederach A (2010) Disease-associated mutations that alter the RNA structural ensemble. PLoS Genet 6(8):e1001074. doi:10.1371/journal.pgen.1001074
Hastings ML, Krainer AR (2001) Pre-mRNA splicing in the new millennium. Curr Opin Cell Biol 13(3):302–309
Hebsgaard SM, Korning PG, Tolstrup N, Engelbrecht J, Rouze P, Brunak S (1996) Splice site prediction in Arabidopsis thaliana pre-mRNA by combining local and global sequence information. Nucleic Acids Res 24(17):3439–3452
Hertz GZ, Stormo GD (1999) Identifying DNA and protein patterns with statistically significant alignments of multiple sequences. Bioinformatics 15(7–8):563–577
Hoskins AA, Moore MJ (2012) The spliceosome: a flexible, reversible macromolecular machine. Trends Biochem Sci 37(5):179–188. doi:10.1016/j.tibs.2012.02.009
Jorde LB, Carey JC, White RL (1996) Medical genetics. Mosby Inc., Orlando
Jurica MS, Moore MJ (2002) Capturing splicing complexes to study structure and mechanism. Methods 28(3):336–345
Jurica MS, Moore MJ (2003) Pre-mRNA splicing: awash in a sea of proteins. Mol Cell 12(1):5–14
Kanopka A, Muhlemann O, Akusjarvi G (1996) Inhibition by SR proteins of splicing of a regulated adenovirus pre-mRNA. Nature 381(6582):535–538. doi:10.1038/381535a0
Ke S, Shang S, Kalachikov SM, Morozova I, Yu L, Russo JJ, Ju J, Chasin LA (2011) Quantitative evaluation of all hexamers as exonic splicing elements. Genome Res 21(8):1360–1374. doi:10.1101/gr.119628.110
Knudsen B, Hein J (1999) RNA secondary structure prediction using stochastic context-free grammars and evolutionary history. Bioinformatics 15(6):446–454
Knudsen B, Hein J (2003) Pfold: RNA secondary structure prediction using stochastic context-free grammars. Nucleic Acids Res 31(13):3423–3428
Krainer AR, Maniatis T, Ruskin B, Green MR (1984) Normal and mutant human beta-globin pre-mRNAs are faithfully and efficiently spliced in vitro. Cell 36(4):993–1005
Kralovicova J, Vorechovsky I (2007) Global control of aberrant splice-site activation by auxiliary splicing sequences: evidence for a gradient in exon and intron definition. Nucleic Acids Res 35(19):6399–6413. doi:10.1093/nar/gkm680
Kralovicova J, Houngninou-Molango S, Kramer A, Vorechovsky I (2004) Branch site haplotypes that control alternative splicing. Hum Mol Genet 13(24):3189–3202. doi:10.1093/hmg/ddh334
Krawczak M, Reiss J, Cooper DN (1992) The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 90(1–2):41–54
Krawczak M, Ball EV, Fenton I, Stenson PD, Abeysinghe S, Thomas N, Cooper DN (2000) Human gene mutation database-a biomedical information and research resource. Hum Mutat 15(1):45–51
Lander ES (1996) The new genomics: global views of biology. Science 274(5287):536–539
Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, Funke R, Gage D, Harris K, Heaford A, Howland J, Kann L, Lehoczky J, LeVine R, McEwan P, McKernan K, Meldrim J, Mesirov JP, Miranda C, Morris W, Naylor J, Raymond C, Rosetti M, Santos R, Sheridan A, Sougnez C, Stange-Thomann N, Stojanovic N, Subramanian A, Wyman D, Rogers J, Sulston J, Ainscough R, Beck S, Bentley D, Burton J, Clee C, Carter N, Coulson A, Deadman R, Deloukas P, Dunham A, Dunham I, Durbin R, French L, Grafham D, Gregory S, Hubbard T, Humphray S, Hunt A, Jones M, Lloyd C, McMurray A, Matthews L, Mercer S, Milne S, Mullikin JC, Mungall A, Plumb R, Ross M, Shownkeen R, Sims S, Waterston RH, Wilson RK, Hillier LW, McPherson JD, Marra MA, Mardis ER, Fulton LA, Chinwalla AT, Pepin KH, Gish WR, Chissoe SL, Wendl MC, Delehaunty KD, Miner TL, Delehaunty A, Kramer JB, Cook LL, Fulton RS, Johnson DL, Minx PJ, Clifton SW, Hawkins T, Branscomb E, Predki P, Richardson P, Wenning S, Slezak T, Doggett N, Cheng JF, Olsen A, Lucas S, Elkin C, Uberbacher E, Frazier M, Gibbs RA, Muzny DM, Scherer SE, Bouck JB, Sodergren EJ, Worley KC, Rives CM, Gorrell JH, Metzker ML, Naylor SL, Kucherlapati RS, Nelson DL, Weinstock GM, Sakaki Y, Fujiyama A, Hattori M, Yada T, Toyoda A, Itoh T, Kawagoe C, Watanabe H, Totoki Y, Taylor T, Weissenbach J, Heilig R, Saurin W, Artiguenave F, Brottier P, Bruls T, Pelletier E, Robert C, Wincker P, Smith DR, Doucette-Stamm L, Rubenfield M, Weinstock K, Lee HM, Dubois J, Rosenthal A, Platzer M, Nyakatura G, Taudien S, Rump A, Yang H, Yu J, Wang J, Huang G, Gu J, Hood L, Rowen L, Madan A, Qin S, Davis RW, Federspiel NA, Abola AP, Proctor MJ, Myers RM, Schmutz J, Dickson M, Grimwood J, Cox DR, Olson MV, Kaul R, Shimizu N, Kawasaki K, Minoshima S, Evans GA, Athanasiou M, Schultz R, Roe BA, Chen F, Pan H, Ramser J, Lehrach H, Reinhardt R, McCombie WR, de la Bastide M, Dedhia N, Blocker H, Hornischer K, Nordsiek G, Agarwala R, Aravind L, Bailey JA, Bateman A, Batzoglou S, Birney E, Bork P, Brown DG, Burge CB, Cerutti L, Chen HC, Church D, Clamp M, Copley RR, Doerks T, Eddy SR, Eichler EE, Furey TS, Galagan J, Gilbert JG, Harmon C, Hayashizaki Y, Haussler D, Hermjakob H, Hokamp K, Jang W, Johnson LS, Jones TA, Kasif S, Kaspryzk A, Kennedy S, Kent WJ, Kitts P, Koonin EV, Korf I, Kulp D, Lancet D, Lowe TM, McLysaght A, Mikkelsen T, Moran JV, Mulder N, Pollara VJ, Ponting CP, Schuler G, Schultz J, Slater G, Smit AF, Stupka E, Szustakowski J, Thierry-Mieg D, Thierry-Mieg J, Wagner L, Wallis J, Wheeler R, Williams A, Wolf YI, Wolfe KH, Yang SP, Yeh RF, Collins F, Guyer MS, Peterson J, Felsenfeld A, Wetterstrand KA, Patrinos A, Morgan MJ, de Jong P, Catanese JJ, Osoegawa K, Shizuya H, Choi S, Chen YJ (2001) Initial sequencing and analysis of the human genome. Nature 409(6822): 860–921
Lareau LF, Inada M, Green RE, Wengrod JC, Brenner SE (2007) Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements. Nature 446(7138):926–929, doi:nature05676 [pii] 10.1038/nature05676
Lim KH, Fairbrother WG (2012) Spliceman—a computational web server that predicts sequence variations in pre-mRNA splicing. Bioinformatics 28(7):1031–1032. doi:10.1093/bioinformatics/bts074
Lim KH, Ferraris L, Filloux ME, Raphael BJ, Fairbrother WG (2011) Using positional distribution to identify splicing elements and predict pre-mRNA processing defects in human genes. Proc Natl Acad Sci U S A 108(27):11093–11098. doi:10.1073/pnas.1101135108
Lin S, Fu XD (2007) SR proteins and related factors in alternative splicing. Adv Exp Med Biol 623:107–122
Lin RJ, Newman AJ, Cheng SC, Abelson J (1985) Yeast mRNA splicing in vitro. J Biol Chem 260(27):14780–14792
Long D, Lee R, Williams P, Chan CY, Ambros V, Ding Y (2007) Potent effect of target structure on microRNA function. Nat Struct Mol Biol 14(4):287–294
Manley JL, Tacke R (1996) SR proteins and splicing control. Genes Dev 10(13):1569–1579
Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, McCarthy MI, Ramos EM, Cardon LR, Chakravarti A, Cho JH, Guttmacher AE, Kong A, Kruglyak L, Mardis E, Rotimi CN, Slatkin M, Valle D, Whittemore AS, Boehnke M, Clark AG, Eichler EE, Gibson G, Haines JL, Mackay TF, McCarroll SA, Visscher PM (2009) Finding the missing heritability of complex diseases. Nature 461(7265):747–753. doi:10.1038/nature08494
Manolio TA, Chisholm RL, Ozenberger B, Roden DM, Williams MS, Wilson R, Bick D, Bottinger EP, Brilliant MH, Eng C, Frazer KA, Korf B, Ledbetter DH, Lupski JR, Marsh C, Mrazek D, Murray MF, O’Donnell PH, Rader DJ, Relling MV, Shuldiner AR, Valle D, Weinshilboum R, Green ED, Ginsburg GS (2013) Implementing genomic medicine in the clinic: the future is here. Genet Med 15(4):258–267. doi:10.1038/gim.2012.157
Martinez-Contreras R, Fisette JF, Nasim FU, Madden R, Cordeau M, Chabot B (2006) Intronic binding sites for hnRNP A/B and hnRNP F/H proteins stimulate pre-mRNA splicing. PLoS Biol 4(2):e21
Maslen C, Babcock D, Raghunath M, Steinmann B (1997) A rare branch-point mutation is associated with missplicing of fibrillin-2 in a large family with congenital contractural arachnodactyly. Am J Hum Genet 60(6):1389–1398. doi:10.1086/515472
Matlin AJ, Moore MJ (2007) Spliceosome assembly and composition. Adv Exp Med Biol 623:14–35
McNally LM, McNally MT (1996) SR protein splicing factors interact with the Rous sarcoma virus negative regulator of splicing element. J Virol 70(2):1163–1172
Meyer M, Plass M, Perez-Valle J, Eyras E, Vilardell J (2011) Deciphering 3´ss selection in the yeast genome reveals an RNA thermosensor that mediates alternative splicing. Mol Cell 43(6):1033–1039. doi:10.1016/j.molcel.2011.07.030
Nielsen KB, Sorensen S, Cartegni L, Corydon TJ, Doktor TK, Schroeder LD, Reinert LS, Elpeleg O, Krainer AR, Gregersen N, Kjems J, Andresen BS (2007) Seemingly neutral polymorphic variants may confer immunity to splicing-inactivating mutations: a synonymous SNP in exon 5 of MCAD protects from deleterious mutations in a flanking exonic splicing enhancer. Am J Hum Genet 80(3):416–432. doi:10.1086/511992
O’Brien K, Matlin AJ, Lowell AM, Moore MJ (2008) The biflavonoid isoginkgetin is a general inhibitor of Pre-mRNA splicing. J Biol Chem 283(48):33147–33154. doi:10.1074/jbc.M805556200
Pagani F, Buratti E, Stuani C, Bendix R, Dork T, Baralle FE (2002) A new type of mutation causes a splicing defect in ATM. Nat Genet 30(4):426–429. doi:10.1038/ng858
Pagani F, Stuani C, Tzetis M, Kanavakis E, Efthymiadou A, Doudounakis S, Casals T, Baralle FE (2003) New type of disease causing mutations: the example of the composite exonic regulatory elements of splicing in CFTR exon 12. Hum Mol Genet 12(10):1111–1120
Pagani F, Raponi M, Baralle FE (2005) Synonymous mutations in CFTR exon 12 affect splicing and are not neutral in evolution. Proc Natl Acad Sci U S A 102(18):6368–6372. doi:10.1073/pnas.0502288102
Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ (2008) Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet 40(12):1413–1415. doi:10.1038/ng.259
Perez I, Lin CH, McAfee JG, Patton JG (1997) Mutation of PTB binding sites causes misregulation of alternative 3´ splice site selection in vivo. RNA 3(7):764–778
Pleiss JA, Whitworth GB, Bergkessel M, Guthrie C (2007) Transcript specificity in yeast pre-mRNA splicing revealed by mutations in core spliceosomal components. PLoS Biol 5(4):e90. doi:10.1371/journal.pbio.0050090
Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38(8):904–909. doi:10.1038/ng1847
Ramachandran S, Deshpande O, Roseman CC, Rosenberg NA, Feldman MW, Cavalli-Sforza LL (2005) Support from the relationship of genetic and geographic distance in human populations for a serial founder effect originating in Africa. Proc Natl Acad Sci U S A 102(44):15942–15947. doi:10.1073/pnas.0507611102
Ranum LP, Cooper TA (2006) RNA-mediated neuromuscular disorders. Annu Rev Neurosci 29:259–277. doi:10.1146/annurev.neuro.29.051605.113014
Reese MG, Eeckman FH, Kulp D, Haussler D (1997) Improved splice site detection in Genie. J Comput Biol 4(3):311–323
Reich DE, Schaffner SF, Daly MJ, McVean G, Mullikin JC, Higgins JM, Richter DJ, Lander ES, Altshuler D (2002) Human genome sequence variation and the influence of gene history, mutation and recombination. Nat Genet 32(1):135–142
Reid DC, Chang BL, Gunderson SI, Alpert L, Thompson WA, Fairbrother WG (2009) Next-generation SELEX identifies sequence and structural determinants of splicing factor binding in human pre-mRNA sequence. RNA 15(12):2385–2397. doi:10.1261/rna.1821809
Robberson BL, Cote GJ, Berget SM (1990) Exon definition may facilitate splice site selection in RNAs with multiple exons. Mol Cell Biol 10(1):84–94
Roca X, Akerman M, Gaus H, Berdeja A, Bennett CF, Krainer AR (2012) Widespread recognition of 5´ splice sites by noncanonical base-pairing to U1 snRNA involving bulged nucleotides. Genes Dev 26(10):1098–1109. doi:10.1101/gad.190173.112
Ruskin B, Krainer AR, Maniatis T, Green MR (1984) Excision of an intact intron as a novel lariat structure during pre-mRNA splicing in vitro. Cell 38(1):317–331
Sabeti PC, Reich DE, Higgins JM, Levine HZ, Richter DJ, Schaffner SF, Gabriel SB, Platko JV, Patterson NJ, McDonald GJ, Ackerman HC, Campbell SJ, Altshuler D, Cooper R, Kwiatkowski D, Ward R, Lander ES (2002) Detecting recent positive selection in the human genome from haplotype structure. Nature 419(6909):832–837
Sachidanandam R, Weissman D, Schmidt SC, Kakol JM, Stein LD, Marth G, Sherry S, Mullikin JC, Mortimore BJ, Willey DL, Hunt SE, Cole CG, Coggill PC, Rice CM, Ning Z, Rogers J, Bentley DR, Kwok PY, Mardis ER, Yeh RT, Schultz B, Cook L, Davenport R, Dante M, Fulton L, Hillier L, Waterston RH, McPherson JD, Gilman B, Schaffner S, Van Etten WJ, Reich D, Higgins J, Daly MJ, Blumenstiel B, Baldwin J, Stange-Thomann N, Zody MC, Linton L, Lander ES, Altshuler D (2001) A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409(6822):928–933
Schwartz S, Ast G (2010) Chromatin density and splicing destiny: on the cross-talk between chromatin structure and splicing. EMBO J 29(10):1629–1636. doi:10.1038/emboj.2010.71
Sciabica KS, Hertel KJ (2006) The splicing regulators Tra and Tra2 are unusually potent activators of pre-mRNA splicing. Nucleic Acids Res 34(22):6612–6620
Siddharthan R (2007) Parsing regulatory DNA: general tasks, techniques, and the PhyloGibbs approach. J Biosci 32(5):863–870
Singh R, Valcarcel J, Green MR (1995) Distinct binding specificities and functions of higher eukaryotic polypyrimidine tract-binding proteins. Science 268(5214):1173–1176
Smith PJ, Zhang C, Wang J, Chew SL, Zhang MQ, Krainer AR (2006) An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers. Hum Mol Genet 15(16):2490–2508. doi:10.1093/hmg/ddl171
Steiner B, Truninger K, Sanz J, Schaller A, Gallati S (2004) The role of common single-nucleotide polymorphisms on exon 9 and exon 12 skipping in nonmutated CFTR alleles. Hum Mutat 24(2):120–129. doi:10.1002/humu.20064
Steitz JA, Dreyfuss G, Krainer AR, Lamond AI, Matera AG, Padgett RA (2008) Where in the cell is the minor spliceosome? Proc Natl Acad Sci U S A 105(25):8485–8486. doi:10.1073/pnas.0804024105
Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NS, Abeysinghe S, Krawczak M, Cooper DN (2003) Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat 21(6):577–581
Sterne-Weiler T, Howard J, Mort M, Cooper DN, Sanford JR (2011) Loss of exon identity is a common mechanism of human inherited disease. Genome Res 21(10):1563–1571. doi:10.1101/gr.118638.110
Stoltenburg R, Reinemann C, Strehlitz B (2007) SELEX–a (r)evolutionary method to generate high-affinity nucleic acid ligands. Biomol Eng 24(4):381–403, doi:S1389-0344(07)00066-4 [pii] 10.1016/j.bioeng.2007.06.001
Sun H, Chasin LA (2000) Multiple splicing defects in an intronic false exon. Mol Cell Biol 20(17):6414–6425
Taggart AJ, DeSimone AM, Shih JS, Filloux ME, Fairbrother WG (2012) Large-scale mapping of branchpoints in human pre-mRNA transcripts in vivo. Nat Struct Mol Biol 19(7):719–721. doi:10.1038/nsmb.2327
Tantin D, Gemberling M, Callister C, Fairbrother W (2008) High-throughput biochemical analysis of in vivo location data reveals novel distinct classes of POU5F1(Oct4)/DNA complexes. Genome Res 18(4):631–639
Teraoka SN, Telatar M, Becker-Catania S, Liang T, Onengut S, Tolun A, Chessa L, Sanal O, Bernatowska E, Gatti RA, Concannon P (1999) Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences. Am J Hum Genet 64(6):1617–1631. doi:10.1086/302418
Ule J, Stefani G, Mele A, Ruggiu M, Wang X, Taneri B, Gaasterland T, Blencowe BJ, Darnell RB (2006) An RNA map predicting Nova-dependent splicing regulation. Nature 444(7119):580–586. doi:10.1038/nature05304
Vorechovsky I (2006) Aberrant 3´ splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization. Nucleic Acids Res 34(16):4630–4641. doi:10.1093/nar/gkl535
Wang GS, Cooper TA (2007) Splicing in disease: disruption of the splicing code and the decoding machinery. Nat Rev Genet 8(10):749–761. doi:10.1038/nrg2164
Wang Z, Rolish ME, Yeo G, Tung V, Mawson M, Burge CB (2004) Systematic identification and analysis of exonic splicing silencers. Cell 119(6):831–845. doi:10.1016/j.cell.2004.11.010
Wang Z, Xiao X, Van Nostrand E, Burge CB (2006) General and specific functions of exonic splicing silencers in splicing control. Mol Cell 23(1):61–70. doi:10.1016/j.molcel.2006.05.018
Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, Kingsmore SF, Schroth GP, Burge CB (2008) Alternative isoform regulation in human tissue transcriptomes. Nature 456(7221):470–476. doi:10.1038/nature07509
Waters KM, Stram DO, Hassanein MT, Le Marchand L, Wilkens LR, Maskarinec G, Monroe KR, Kolonel LN, Altshuler D, Henderson BE, Haiman CA (2010) Consistent association of type 2 diabetes risk variants found in Europeans in diverse racial and ethnic groups. PLoS Genet 6(8). doi:10.1371/journal.pgen.1001078
Watkins KH, Stewart A, Fairbrother W (2009) A rapid high-throughput method for mapping ribonucleoproteins (RNPs) on human pre-mRNA. J Vis Exp. (34)
Waugh JL, Celver J, Sharma M, Dufresne RL, Terzi D, Risch SC, Fairbrother WG, Neve RL, Kane JP, Malloy MJ, Pullinger CR, Gu HF, Tsatsanis C, Hamilton SP, Gold SJ, Zachariou V, Kovoor A (2011) Association between regulator of G protein signaling 9-2 and body weight. PLoS One 6(11):e27984. doi:10.1371/journal.pone.0027984
Webb JC, Patel DD, Shoulders CC, Knight BL, Soutar AK (1996) Genetic variation at a splicing branch point in intron 9 of the low density lipoprotein (LDL)-receptor gene: a rare mutation that disrupts mRNA splicing in a patient with familial hypercholesterolaemia and a common polymorphism. Hum Mol Genet 5(9):1325–1331
Yajima M, Fairbrother WG, Wessel GM (2012) ISWI contributes to ArsI insulator function in development of the sea urchin. Development 139(19):3613–3622. doi:10.1242/dev.081828
Yeo G, Burge CB (2004) Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J Comput Biol 11(2–3):377–394. doi:10.1089/1066527041410418
Yeo GW, Van Nostrand E, Holste D, Poggio T, Burge CB (2005) Identification and analysis of alternative splicing events conserved in human and mouse. Proc Natl Acad Sci U S A 102(8):2850–2855, doi:0409742102 [pii] 10.1073/pnas.0409742102
Zhang XH, Chasin LA (2004) Computational definition of sequence motifs governing constitutive exon splicing. Genes Dev 18(11):1241–1250. doi:10.1101/gad.1195304
Zhang XH, Leslie CS, Chasin LA (2005a) Dichotomous splicing signals in exon flanks. Genome Res 15(6):768–779. doi:10.1101/gr.3217705
Zhang XH, Leslie CS, Chasin LA (2005b) Computational searches for splicing signals. Methods 37(4):292–305. doi:10.1016/j.ymeth.2005.07.011
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Soemedi, R., Vega, H., Belmont, J.M., Ramachandran, S., Fairbrother, W.G. (2014). Genetic Variation and RNA Binding Proteins: Tools and Techniques to Detect Functional Polymorphisms. In: Yeo, G. (eds) Systems Biology of RNA Binding Proteins. Advances in Experimental Medicine and Biology, vol 825. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1221-6_7
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1221-6_7
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1220-9
Online ISBN: 978-1-4939-1221-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)